Apogee Therapeutics Files 8-K
Ticker: APGE · Form: 8-K · Filed: Jul 7, 2025 · CIK: 1974640
| Field | Detail |
|---|---|
| Company | Apogee Therapeutics, Inc. (APGE) |
| Form Type | 8-K |
| Filed Date | Jul 7, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, regulatory
Related Tickers: APTG
TL;DR
APTG filed an 8-K on 7/7/25, likely routine financials/updates.
AI Summary
On July 7, 2025, Apogee Therapeutics, Inc. filed an 8-K report. The filing primarily concerns other events and financial statements, with no specific material events or transactions detailed in the provided excerpt. The company is incorporated in Delaware and headquartered in Waltham, MA.
Why It Matters
This 8-K filing indicates that Apogee Therapeutics has submitted a routine report to the SEC, which may contain updates on financial statements or other corporate events.
Risk Assessment
Risk Level: low — The provided excerpt is a standard 8-K filing notification and does not contain information about material events, financial performance, or significant business changes that would indicate a high or medium risk.
Key Players & Entities
- Apogee Therapeutics, Inc. (company) — Registrant
- July 7, 2025 (date) — Date of earliest event reported
- Waltham, MA (location) — Principal Executive Offices
- 001-41740 (other) — Commission File Number
FAQ
What is the primary purpose of this 8-K filing for Apogee Therapeutics, Inc.?
The filing is a Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934, with the date of the earliest event reported being July 7, 2025. It indicates items related to Regulation FD Disclosure, Other Events, and Financial Statements and Exhibits.
When was Apogee Therapeutics, Inc. formerly known as Apogee Therapeutics, LLC?
The company was formerly known as Apogee Therapeutics, LLC, with a date of name change on April 20, 2023.
What is Apogee Therapeutics, Inc.'s principal executive office address?
The principal executive offices are located at 221 Crescent Street, Building 17, Suite 102b, Waltham, MA, 02453.
What is the Commission File Number for Apogee Therapeutics, Inc.?
The Commission File Number for Apogee Therapeutics, Inc. is 001-41740.
What is the SIC code for Apogee Therapeutics, Inc.?
The Standard Industrial Classification (SIC) code for Apogee Therapeutics, Inc. is 2836, which corresponds to Biological Products (No Diagnostic Substances).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 7, 2025 regarding Apogee Therapeutics, Inc. (APGE).